MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, APLS has $1,082,532K in assets. $667,609K in debts. $405,207K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
362.68%
Quick Ratio
316.32%
Cash Ratio
142.96%
Debt to Asset Ratio
61.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Accounts receivable, net
    • Cash and cash equivalents
    • Inventory
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term credit facility
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
405,207 466,233 479,171 370,036
Accounts receivable, net
440,299 366,221 345,538 214,131
Inventory
131,408 142,556 122,819 121,000
Prepaid assets
--31,560 29,171
Prepaid and other current assets
49,587 38,303 --
Restricted cash
1,520 1,527 1,430 1,430
Other current assets
--10,158 19,842
Total current assets
1,028,021 1,014,840 990,676 755,610
Right-of-use assets
18,945 18,195 19,720 14,637
Property and equipment, net
1,418 1,708 1,927 2,117
Long-term inventory
28,489 34,959 40,909 48,128
Other assets
5,659 5,555 5,491 898
Total assets
1,082,532 1,075,257 1,058,723 821,390
Accounts payable
49,049 56,798 38,602 54,241
Accrued expenses
133,693 166,049 140,322 138,999
Convertible senior notes
93,744 93,662 93,581 -
Current portion of lease liabilities
6,962 7,087 7,022 7,419
Total current liabilities
283,448 323,596 279,527 200,659
Long-term credit facility
362,243 361,664 361,091 360,535
Convertible senior notes
-0 0 93,500
Lease liabilities
12,807 11,947 13,680 8,313
Other liabilities
9,111 7,903 3,257 2,078
Total liabilities
667,609 705,110 657,555 665,085
Common stock, 0.0001 par value 200,000 shares authorized at march 31, 2026 and december 31, 2025 127,923 shares issued and outstanding at march 31, 2026, and 126,621 shares issued and outstanding at december 31, 2025
13 12 12 12
Additional paid-in capital
3,411,643 3,385,216 3,357,583 3,328,604
Accumulated other comprehensive loss
-2,411 -2,103 -2,400 -2,569
Accumulated deficit
-2,994,322 -3,012,978 -2,954,027 -3,169,742
Total stockholders' equity
414,923 370,147 401,168 156,305
Total liabilities and stockholders' equity
1,082,532 1,075,257 1,058,723 821,390
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$440,299K (87.17%↑ Y/Y)Cash and cashequivalents$405,207K (13.06%↑ Y/Y)Inventory$131,408K (59.34%↑ Y/Y)Prepaid and othercurrent assets$49,587K Restricted cash$1,520K (6.00%↑ Y/Y)Total current assets$1,028,021K (41.27%↑ Y/Y)Long-term inventory$28,489K (-53.03%↓ Y/Y)Right-of-use assets$18,945K (24.22%↑ Y/Y)Other assets$5,659K (392.09%↑ Y/Y)Property and equipment,net$1,418K (-43.60%↓ Y/Y)Total assets$1,082,532K (34.10%↑ Y/Y)Total liabilities andstockholders' equity$1,082,532K (34.10%↑ Y/Y)Total liabilities$667,609K (3.82%↑ Y/Y)Total stockholders'equity$414,923K (152.67%↑ Y/Y)Accumulated deficit-$2,994,322K (4.26%↑ Y/Y)Accumulated othercomprehensive loss-$2,411K (21.05%↑ Y/Y)Long-term credit facility$362,243K (0.62%↑ Y/Y)Total currentliabilities$283,448K (58.90%↑ Y/Y)Lease liabilities$12,807K (39.42%↑ Y/Y)Other liabilities$9,111K (337.19%↑ Y/Y)Additional paid-in capital$3,411,643K (3.54%↑ Y/Y)Common stock, 0.0001par value 200,000...$13K (8.33%↑ Y/Y)Accrued expenses$133,693K (15.11%↑ Y/Y)Convertible senior notes$93,744K (0.35%↑ Y/Y)Accounts payable$49,049K (-11.28%↓ Y/Y)Current portion of leaseliabilities$6,962K (0.26%↑ Y/Y)

APLS_BIG copy-svg

Apellis Pharmaceuticals, Inc. (APLS)

APLS_BIG copy-svg

Apellis Pharmaceuticals, Inc. (APLS)